Inhibition by protamine of catecholamine secretion and ion influxes in bovine adrenal medullary cells in culture

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 838-843

  Minami, Kouichiro ^a   Yanagihara, Nobuyuki ^a   Segawa, Kayoko ^a   Sata, Takeyoshi ^a   Tsutsui, Masato ^a   Shigematsu, Akio ^a   Izumi, Futoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; NORADRENALIN; PROTAMINE;

ADRENAL MEDULLA; ANIMAL CELL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CATTLE; DRUG EFFECT; HORMONAL REGULATION; HYPOTENSION; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRIORITY JOURNAL; SODIUM TRANSPORT; SYMPATHETIC NERVE;

ADRENAL MEDULLA; ANIMALS; BLOOD PRESSURE; CALCIUM; CARBACHOL; CATECHOLAMINES; CATTLE; CELLS, CULTURED; HEPARIN; MALE; NOREPINEPHRINE; PROTAMINES; RATS; RATS, WISTAR; SODIUM; VERATRIDINE;

EID: 0030441049     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. AKATA, T., KODAMA, K. AND TAKAHASHI, S.: Effects of heparin on the vasodilator action of protamine in the rabbit mesenteric artery. Br. J. Pharmacol. 109: 1247-1253, 1993.
2. AKATA, T., YOSHITAKE, J., NAKASHIMA, M. AND ITOH, T.: Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. Anesthesiology 75: 833-846, 1991.
3. + uptake and catecholamine secretion by primary cultures of adrenal medullary cells. J. Neurochem. 39: 132-142, 1982.
4. ANDO, T. AND SUZUKI, K.: The amino acid sequence of the second component of clupeine. Biochim. Biophys. Acta 121: 427-429, 1966.
5. CONAHAN, T. J. III, ANDREWS, R. W. AND MAC VAUGH, H. III: Cardiovascular effects of protamine sulfate in man. Anesth. Analg. 60: 33-36, 1981.
6. FADALI, M. A., LEDBETTER, M., PAPACOSTAS, C. A., DUKE, L. J. AND LEMOLE, G. M.: Mechanism responsible for the cardiovascular depressant effect of protamine sulfate. Ann. Surg. 180: 232-235, 1974.
7. GOLDMAN, B. S., JOISON, J. AND AUSTEN, W. G.: Cardiovascular effects of protamine sulfate. Ann. Thor. Surg. 7: 459-471, 1969.
8. GOURIN, A., STREISAND, R. L., GREINEDER, J. K. AND STUCKEY, J. H.: Protamine sulfate administration and the cardiovascular system. J. Thorac. Cardiovasc. Surg. 62: 193-204, 1971.
9. GUYTON, A. C.: Textbook of Medical Physiology, 8th ed. Local control of blood flow by the tissues, and humoral regulation, pp. 185-193, W. B. Saunders, Philadelphia, 1991.
10. HASEGAWA, T., YOKOTANI, K., OKUMA, Y., MANABE, M., HIRAKAWA, M. AND OSUMI, Y.: Microinjection of α-calcitonin gene-related peptide into the hypothalamus activates sympathetic outflow in rats. Jpn. J. Pharmacol. 61: 325-332, 1993.
11. HINES, R. L. AND BARASH, P. G.: Protamine: does it alter right ventricular function? Anesth. Analg. 68: 1271-1274, 1986.
12. HOBBHAHN, J., CONZEN, P. F., ZENKER, B., GOETZ, A. E., PETER, K. AND BRENDEL, W.: Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine. Anesth. Analg. 67: 253-260, 1988.
13. HORROW, J. C.: Protamine: A review of its toxicity. Anesth. Analg. 64: 348-361, 1985.
14. HORROW, J. C.: Heparin reversal of protamine toxicity: Have we come full circle? J. Cardiothorac. Vasc. Anesth. 4: 539-542, 1990.
15. JAQUES, L. B.: A study of the toxicity of the protamine, salmine. Br. J. Pharmacol. 4: 135-144, 1949.
16. KILPATRICK, D. L., SPEPETIS, R. J., CORCORAN, J. J. AND KIRSHNER, N.: Calcium uptake and catecholamine secretion by cultured bovine adrenal medulla cells. J. Neurochem. 38: 427-435, 1982.
17. LOWENSTEIN, E. AND ZAPOL, W. M.: Protamine reactions, explosive mediator release, and pulmonary vasoconstriction. Anesthesiology 73: 373-375, 1990.
18. MAJERUS, P. W., BROZE, G. J. J. R., MILETICH, J. P. AND TOLLEFSEN, D. M.: Anticoagulant, thrombolytic, and antiplatelet drugs. In The Pharmacological Basis of Therapeutics. ed. by L. S. Goodman and A. Gilman, pp. 1311-1331, Macmillan Publishing, New York, 1990.
19. MARIN-NETO, J. A., SYKES, M. K., MARIN, J. L. B., ORCHARD, C. AND CHAKRABARTI, M. K.: Effects of heparin and protamine on left ventricular performance in the dog. Cardiovasc. Res. 13: 254-259, 1979.
20. + influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells. Naunyn-Schmideberg Arch. Pharmacol. 349: 223-229, 1994.
21. MOREL, D. R., COSTABELLA, P. M. AND PITTET, J-F.: Adverse cardiovascular effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. Anesthesiology 73: 415-424, 1990.
22. NORDSTRÖM, L., FLETCHER, R. AND PAVEK, K.: Shock of anaphylactoid type induced by protamine: A continuous cardiovascular record. Acta. Anaesth. Scand. 22: 195-201, 1978.
23. SMITH, J. J. AND KAMPINE, J. P.: Regulation of arterial blood pressure. In Circulatory Physiology - The Essentials, ed. by J. J. Smith and J. P. Kampine, eds., pp. 161-181, Williams & Wilkins, Baltimore, 1990.
24. SUMIKAWA, K., AMAKATA, Y., KASHIMOTO, T. AND IZUMI, F.: Effects of cyclopropane on catecholamine release from bovine adrenal medulla. Anesthesiology 53: 49-52, 1980.
25. SUMIKAWA, K., HIRANO, H., AMAKATA, Y., KASHIMOTO, T., WADA, A. AND IZUMI, F.: Mechanism of the effect of droperidol to induce catecholamine efflux from the adrenal medulla. Anesthesiology 62: 17-22, 1985.
26. SUMIKAWA, K., MATSUMOTO, T., ISHIZAKA, N., NAGAI, H., AMENOMORI, Y. AND AMAKATA, Y.: Mechanism of the differential effects of halothane on nicotinic-and muscarinic-receptor-mediated responses of the dog adrenal medulla. Anesthesiology 57: 444-450, 1982.
27. TAYLOR, R. L., LITTLE, W. C., FREEMAN, G. L., AVERY, D. M., NORRIS, S. E., TRINKLE, J. K. AND GROVER, F. L.: Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog. Ann. Thorac. Surg. 42: 22-26, 1986.
28. THIEMERMANN, C., AL-DAMLUJI, S., HECKER, M. AND VANE, J. R.: FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system. Biochem. Biophys. Res. Commun. 175: 318-324, 1991.
29. TSUTSUI, M., YANAGIHARA, N., MINAMI, K., KOBAYASHI, H., NAKASHIMA, Y., KUROIWA, A. AND IZUMI, F.: C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther. 268: 584-589, 1994.
30. URUNO, T., MATSUMOTO, R., OKUSHITA, K., SUNAGANE, N. AND KUBOTA, K.: Possible mechanisms of inhibitory action of protamine on contractile activity of rat aorta. J. Pharm. Pharmacol. 37: 476-480, 1985.
31. 45Ca influx and secretion of catecholamines in cultured bovine adrenal medullary cells. Neuroscience 15: 283-292, 1985.
32. WALLIN, B. G., SUNDLÖF, G., ERIKSSON, B-M., DOMINIAK, P., GROBECKER, H. AND LINDBLAD, L. E.: Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol. Scand. 111: 69-73, 1981.
33. WEIL-MALHEREBE, H. AND BONE, A. D.: The chemical estimation of adrenaline-like substances in blood. Biochem. J. 51: 311-318, 1952.
34. YANAGIHARA, N., ISOSAKI, M., OHUCHI, T. AND OKA, M.: Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells. FEBS. Lett. 105: 296-298, 1979.
35. + removal. J. Neurochem. 49: 1740-1746, 1987.
36. YASHIMA, N., WADA, A. AND IZUMI, F.: Halothane inhibits the cholinergic-receptor-mediated influx of calcium in primary culture of bovine adrenal medulla cells. Anesthesiology, 64: 466-472, 1986.